Assyro AI is a regulatory artificial intelligence company operating in the New York City technology sector[1]. Founded in 2025, the company focuses on serving biopharma and MedTech teams[2]. According to the company's description, Assyro provides AI-powered authoring, validation, and regulatory intelligence tools designed to reduce submission cycle timelines and costs[2]. The company reports that its platform reduces rework by 6+ weeks and $250,000 per submission cycle[2]. Assyro operates within the software development industry[3].
Something wrong or missing? Send a correction. Fixed within 24 hours.